España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
TScan Therapeutics
TCRX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.37
-0.03
-1.25%
At close: -
$2.37
0.00
0.00%
After Hours: 4:01 PM EDT
Get Report
Comment
TScan Therapeutics (TCRX) Forecast
News
Earnings
TScan Therapeutics (TCRX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for TScan Therapeutics (NASDAQ:TCRX) Stock
TScan Therapeutics Stock (NASDAQ: TCRX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, December 26, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Why Is TScan Therapeutics Stock Gaining Today?
Nabaparna Bhattacharya
Market-Moving News for December 26th
Benzinga Newsdesk
TScan Therapeutics Enters Securities Purchase...
Benzinga Newsdesk
Wednesday, December 11, 2024
The Analyst Landscape: 5 Takes On TScan Therapeutics
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on TScan T...
Benzinga Newsdesk
Needham Reiterates Buy on TScan Therapeutics,...
Benzinga Newsdesk
Monday, December 09, 2024
TScan Therapeutics To Present Updated Results...
Benzinga Newsdesk
Friday, November 15, 2024
HC Wainwright & Co. Reiterates Buy on TScan T...
Benzinga Newsdesk
Tuesday, November 12, 2024
Needham Reiterates Buy on TScan Therapeutics,...
Benzinga Newsdesk
TScan Therapeutics Q3 2024 GAAP EPS $(0.25) B...
Benzinga Newsdesk
Wednesday, November 06, 2024
Demystifying TScan Therapeutics: Insights From 4 Analyst Reviews
Benzinga Insights
Needham Reiterates Buy on TScan Therapeutics,...
Benzinga Newsdesk
Tuesday, November 05, 2024
TScan Therapeutics Announces Oral Presentatio...
Benzinga Newsdesk
Tuesday, August 13, 2024
Expert Outlook: TScan Therapeutics Through The Eyes Of 5 Analysts
Benzinga Insights
Wedbush Reiterates Outperform on TScan Therap...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on TScan T...
Benzinga Newsdesk
Monday, August 12, 2024
Needham Reiterates Buy on TScan Therapeutics,...
Benzinga Newsdesk
TScan Therapeutics' Cash, Cash Equivalents, A...
Benzinga Newsdesk
TScan Therapeutics Q2 2024 GAAP EPS $(0.28) B...
Benzinga Newsdesk
Tuesday, June 04, 2024
The Analyst Landscape: 7 Takes On TScan Therapeutics
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on TScan T...
Benzinga Newsdesk
Wednesday, May 29, 2024
TScan Therapeutics Says FDA Granted Regenerat...
Benzinga Newsdesk
Thursday, May 16, 2024
BTIG Initiates Coverage On TScan Therapeutics...
Benzinga Newsdesk
Tuesday, May 14, 2024
HC Wainwright & Co. Reiterates Buy on TScan T...
Benzinga Newsdesk
Monday, May 13, 2024
Key Takeaways From TScan Therapeutics Analyst Ratings
Benzinga Insights
TScan Therapeutics' Existing Cash Resources O...
Benzinga Newsdesk
TScan Therapeutics Q1 2024 GAAP EPS $(0.32) M...
Benzinga Newsdesk
Needham Reiterates Buy on TScan Therapeutics,...
Benzinga Newsdesk
Thursday, May 09, 2024
TScan Therapeutics Doses First Patient In Pha...
Benzinga Newsdesk
Tuesday, April 23, 2024
Unveiling 4 Analyst Insights On TScan Therapeutics
Benzinga Insights
Wedbush Reiterates Outperform on TScan Therap...
Benzinga Newsdesk
Wednesday, April 17, 2024
TScan Therapeutics Prices Upsized $150M Publi...
Benzinga Newsdesk
Tuesday, April 16, 2024
TScan Therapeutics shares are trading lower a...
Benzinga Newsdesk
TScan Therapeutics Reports Launch Of $125M Pr...
Benzinga Newsdesk
TScan Therapeutics Provides Update On Its Sol...
Benzinga Newsdesk
Friday, March 22, 2024
Worthington Steel Posts Upbeat Results, Joins Summit Midstream Partners, FedEx And Other Big Stocks Moving Higher On Friday
Avi Kapoor
Thursday, March 07, 2024
Barclays Maintains Overweight on TScan Therap...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on TScan T...
Benzinga Newsdesk
Wednesday, March 06, 2024
TScan Therapeutics: Q4 Earnings Insights
Benzinga Insights
TScan Therapeutics Q4 EPS $(0.21) Beats $(0.2...
Benzinga Newsdesk
Monday, February 26, 2024
TScan Therapeutics Presents Updated Phase 1 C...
Benzinga Newsdesk
Wednesday, February 14, 2024
TScan Therapeutics Will Host A Virtual Key Op...
Benzinga Newsdesk
Thursday, February 01, 2024
Wedbush Reiterates Outperform on TScan Therap...
Benzinga Newsdesk
Monday, January 29, 2024
TScan Therapeutics Has Appointed Jason Amello...
Benzinga Newsdesk
Thursday, January 18, 2024
TScan Therapeutics Announced The Acceptance O...
Benzinga Newsdesk
Monday, December 11, 2023
TScan Therapeutics on Saturday Presented Initial Phase 1 Clinical Results on TSC-100 and TSC-101 at the 65th American Society of Hematology Annual Meeting and Exposition
Charles Gross
Monday, December 04, 2023
TScan Therapeutics To Host Virtual KOL Event ...
Benzinga Newsdesk
Thursday, November 09, 2023
Recap: TScan Therapeutics Q3 Earnings
Benzinga Insights
TScan Therapeutics Ended Q3 With Cash, Cash E...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
